课题基金 / 基金详情

STUDIES OF BENZ(A)ANTHRAQUINONE ANTIBIOTICS

STUDIES OF BENZ(A)ANTHRAQUINONE ANTIBIOTICS
苯并(A)蒽醌类抗生素的研究
批准号:
2684753
负责人:
PHILIP J. PROTEAU
金额:
$21.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1982
资助国家:
美国
项目状态:
已结题
起止时间:
1982-12-01 至 1999-09-30

项目摘要

项目成果

PHILIP J. PROTEAU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The specific aims of this program focus on benz[a]anthraquinone- derived antibiotics. Work will be continued on the kinamycin antibiotics produced by Streptomyces murayamaensis, and on antibiotic PD 116740, produced by S. WP 4669. A limited set of experiments will be carried out in S. rimosus, in order to identify one of the key branch-points in the general matrix of benz[a]anthraquinone biosynthesis by examining the precursor/product relationship of tetrangomycin and tetrangulol. The Research Design includes structural studies to identify more biosynthetic intermediates in each pathway. This will be done by a combination of characterizing additional metabolites, and of synthesizing and testing reasonable candidates. In the kinamycin pathway, metabolites that are potentially intermediates will be identified by feeding known intermediates to a current set of 37 blocked mutants. The Research Design will include biochemical studies to detect and characterize key enzymes in these pathways (e.g. for amino- and amidotransferases, aryl epoxidases and arylepoxide hydrolases, hydroquinone epoxidases, and aromatic ringcleaving enzymes), and molecular genetics studies to clone, sequence, and characterize selected genes. The broad objective of this research program is to understand which chemical reactions are available in Nature and how they are linked together to produce complex structures with significant bio- medically relevant activity, in particular, antibiosis. This objective will be attained through the described multi-faceted approach that blends carefully chosen experiments in synthesis, biosynthesis, enzymology and molecular genetics. Such an interdisciplinary approach has become more and more essential for the modern bioorganic chemist who desires to study metabolism, its regulation and its consequences. It will lay the groundwork for applications such as modifying bioactivity by metabolic and genetic engineering to generate new molecular structures. This interdisciplinary approach is also an effective vehicle to train new chemists with an understanding of biology and a broad range of skills for solving important biochemical problems.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Kinamycin acetyltransferase I from Streptomyces murayamaensis, an apparently large, membrane-associated enzyme.
来自村山链霉菌的动霉素乙酰转移酶 I,一种明显较大的膜相关酶。
DOI: 10.1016/0968-0896(96)00097-1
发表时间: 1996
期刊: Bioorganic & medicinal chemistry
影响因子: 3.5
作者: [Gould,SJ, O'Hare,T, Seaton,P, Soodsma,J, Tang,Z]
通讯作者: Tang,Z
DOI: 10.7164/antibiotics.42.189
发表时间: 1989-02
期刊: The Journal of antibiotics
影响因子: --
作者: [P. Seaton;S. Gould]
通讯作者: P. Seaton;S. Gould
DOI: 10.1021/np50107a005
发表时间: 1994-05
期刊: Journal of natural products
影响因子: 5.1
作者: [C. Melville;S. Gould]
通讯作者: C. Melville;S. Gould
Pleuromutilin Biosynthetic Studies
  • 批准号:
    8073650
  • 项目类别:
  • 资助金额:
    $18.09万
  • 财政年份:
    2010
  • 负责人:
    PHILIP J. PROTEAU
  • 依托单位:
Pleuromutilin Biosynthetic Studies
  • 批准号:
    7881349
  • 项目类别:
  • 资助金额:
    $21.93万
  • 财政年份:
    2010
  • 负责人:
    PHILIP J. PROTEAU
  • 依托单位:
ISOPRENOID BIOSYNTHESIS: NON-MEVALONATE PATHWAY STUDIES
  • 批准号:
    6631995
  • 项目类别:
  • 资助金额:
    $19.39万
  • 财政年份:
    2000
  • 负责人:
    PHILIP J. PROTEAU
  • 依托单位:
ISOPRENOID BIOSYNTHESIS: NON-MEVALONATE PATHWAY STUDIES
  • 批准号:
    6362343
  • 项目类别:
  • 资助金额:
    $18.28万
  • 财政年份:
    2000
  • 负责人:
    PHILIP J. PROTEAU
  • 依托单位:
海外基金